Orakl Oncology

Orakl Oncology is a precision oncology company developing an AI-powered platform that integrates real-world patient data with biological information to improve drug development decisions. The platform predicts patient response to treatments and increases clinical trial success rates, ultimately accelerating the availability of new cancer therapies. This is achieved by creating ex vivo patient avatars for therapeutic decision-making.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: €11M

Date: 03-Dec-2024

Investors: Singular, Bpifrance

Markets: Oncology, AI, Healthtech, Biotechnology, Drug Discovery, Life Sciences

HQ: Le Kremlin Bicêtre, Île-de-France, France

Founded: 2023

Website: https://www.orakl-oncology.com/

LinkedIn: https://www.linkedin.com/company/orakloncology/

Twitter: https://twitter.com/orakldotbio

Instagram: